" />

Login

Login

Generate password

Change password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Aurobindo Pharma - Curateq Biologics Announces Successful Completion Of Phase 3 Clinical Study For Denosumab Biosimilar.

Share Source By

Dion Global

19 Sep 2025

Submission of disclosure of successful of phase 3 clinical study for Denosumab Biosimilar by CuraTeQ Biologics Private Limited, a wholly owned subsidiary of the Company.